Conference
A phase II trial of oblimersen sodium (G3139) plus rituximab for treatment of patients with recurrent B-cell non-Hodgkin's lymphoma
Authors
Pro B; Leber B; Smith M; Younes A; Fayad L; Hagemeister F; McLaughlin P; Rodriguez M; Kwak LW; Caddick Y
Volume
16
Pagination
pp. 68-68
Publisher
OXFORD UNIV PRESS
Publication Date
June 1, 2005
Name of conference
9th International Conference on Malignant Lymphoma
Conference place
Lugano, SWITZERLAND
Conference start date
June 9, 2005
Conference end date
June 11, 2005
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534